华森制药：收到8个药品的《药品再注册批准通知书》

Core Viewpoint - The company, Watson Pharmaceuticals, has received approval from the Chongqing Municipal Drug Administration for the re-registration of eight pharmaceutical products, indicating a positive regulatory development for the company [1] Group 1: Approved Products - The approved products include: - Injection of Moxifloxacin Mesylate (0.2g and 0.4g) - Injection of Cytidine Diphosphate Choline - Injection of Acyclovir - Xylometazoline Capsules - Injection of Bumetanide - Injection of Calcium Leucovorin (25mg and 100mg) [1]